2 results
Approved WMOCompleted
To determine if there is a difference in the pharmacokinetics of low-dose cisplatin with and without prehydration.
Approved WMOWill not start
The primary objective of this study is to assess tolerance and efficacy of 12 weeks BP1.3656 (30 µg or 60 µg OD versus placebo) to reduce alcohol consumption in alcohol dependent patients.